Although our findings along with previous studies (27, 29), indicate that CXCL13 serum levels in pSS patients may associate with high risk to develop NHL, all studies failed to register CXCL13 serum levels as an independent lymphoma predictor. Here, CXCL13 is linked to peeling skin syndrome.